Green Growth Brands Inc. (GGBXF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGreen Growth Brands Inc. (GGBXF) trades at $0.00001. Green Growth Brands Inc. operates in the cannabis and CBD-infused consumer products market in the United States. Sector: Healthcare.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for GGBXF: GGBXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Green Growth Brands Inc. (GGBXF) Healthcare & Pipeline Overview
Green Growth Brands Inc. focuses on the cultivation, processing, and retail of cannabis and CBD-infused products within the US market. The company operates through multiple brands, offering both medical marijuana and CBD personal care items via dispensaries, e-commerce, and wholesale channels, facing a highly competitive landscape.
What Is the Investment Thesis for GGBXF?
Investing in Green Growth Brands Inc. (GGBXF) involves high risk due to its presence in the volatile cannabis and CBD market. The company's negative profit margin of -408.5% and gross margin of -11.9% indicate significant financial challenges. The beta of -17.52 suggests an inverse correlation with the market, which could be misleading given the company's financial instability. Growth hinges on successful brand establishment and market penetration in a competitive sector. Potential investors should closely monitor regulatory changes, market acceptance of CBD products, and the company's ability to achieve profitability. The absence of a dividend further underscores the speculative nature of this investment.
Based on FMP financials and quantitative analysis
GGBXF Key Highlights
Market Cap of $0.00B indicates a micro-cap company with limited resources and higher volatility.
- P/E Ratio of -0.00 reflects the company's current lack of profitability.
- Profit Margin of -408.5% suggests substantial operational inefficiencies and high costs relative to revenue.
- Gross Margin of -11.9% indicates that the company's cost of goods sold exceeds its revenue, posing a significant challenge to achieving profitability.
- Beta of -17.52 suggests a strong inverse correlation with the market, but may not be reliable due to the company's financial instability.
Who Are GGBXF's Competitors?
GGBXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BIOYF BioSyent Inc. | $11.49 | -0.09% | $131M | — |
| GRUSF Grown Rogue International Inc. | $0.40 | -4.76% | $100M | — |
| HLTRF HLS Therapeutics Inc. | $2.82 | +1.08% | $86.0M | — |
| JUSHF Jushi Holdings Inc. | $0.42 | +2.53% | $84.3M | — |
| LOVFF Cannara Biotech Inc. | $1.48 | 0.00% | $146M | — |
| AKAN Akanda Corp. | $1.91 | -3.54% | — | |
| APUS Apimeds Pharmaceuticals US, Inc. | $4.59 | +42.55% | $7.59M | — |
| BFRI Biofrontera Inc. | $0.89 | -12.23% | $13.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GGBXF's Key Strengths?
Established brand names in the cannabis and CBD market.
- Diverse product portfolio catering to both medical and recreational users.
- Integrated operations from cultivation to retail.
- Presence in key regional markets.
What Are GGBXF's Weaknesses?
Negative profit and gross margins indicating financial instability.
- High operating costs relative to revenue.
- Limited market share compared to larger competitors.
- Dependence on regulatory approvals and market acceptance.
What Are the Key Risks for GGBXF?
Intense competition from established cannabis companies and emerging CBD brands.
- Changing regulatory landscape and potential restrictions on cannabis and CBD products.
- Fluctuations in cannabis prices and supply chain disruptions.
- Negative publicity or health concerns related to cannabis or CBD use.
- The company's current financial instability and negative profit margins pose a significant risk.
What Are GGBXF's Competitive Advantages?
- Brand recognition through established brand names like CAMP and Seventh Sense Botanical Therapy.
- Proprietary cannabis strains and formulations.
- Established distribution network through retail stores and wholesale channels.
- First-mover advantage in select regional markets.
What Does GGBXF Do?
Green Growth Brands Inc., originally founded in 1968 as Xanthic Biopharma Inc. and rebranded in 2019, is a company focused on the cannabis and cannabidiol (CBD) market in the United States. Headquartered in Columbus, Ohio, the company cultivates, processes, produces, distributes, and retails cannabis and CBD-infused consumer products. Its offerings include medical and retail marijuana products supplied to dispensaries, as well as CBD-infused personal care and beauty products such as therapeutic items, face care, body care, shower and bathroom products, and sleep aids. These products are available through the company's retail shops, e-commerce platform, and wholesale distribution channels. Green Growth Brands operates under several brand names, including CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company aims to establish a strong presence in the burgeoning cannabis and CBD market by catering to both medical and recreational consumers.
What Products and Services Does GGBXF Offer?
- Cultivates cannabis plants for medical and recreational use.
- Processes raw cannabis into various consumer products.
- Produces CBD-infused personal care and beauty products.
- Distributes cannabis and CBD products to dispensaries and retailers.
- Retails cannabis and CBD products through company-owned stores.
- Sells products online through its e-commerce platform.
- Markets its products under several brand names, including CAMP and Seventh Sense Botanical Therapy.
How Does GGBXF Make Money?
- Cultivation and processing of cannabis to create raw materials.
- Manufacturing of cannabis and CBD-infused products.
- Direct-to-consumer sales through retail stores and e-commerce.
- Wholesale distribution to dispensaries and other retailers.
What Industry Does GGBXF Operate In?
Green Growth Brands Inc. operates within the rapidly evolving cannabis and CBD industry, which is characterized by increasing legalization and growing consumer acceptance. The market is highly competitive, with numerous players vying for market share in both the medical and recreational segments. Key trends include the expansion of retail dispensaries, the growth of e-commerce platforms for CBD products, and increasing investment in product innovation. Green Growth Brands faces competition from established cannabis companies and emerging CBD brands, requiring strategic differentiation and efficient operations to succeed.
Who Are GGBXF's Key Customers?
- Medical marijuana patients seeking therapeutic relief.
- Recreational cannabis users.
- Consumers of CBD-infused personal care and beauty products.
- Wholesale clients, including dispensaries and retailers.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Green Growth Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Columbus, US. The company is led by CEO Ed Kistner. GGBXF has traded publicly since 2018.
Key Financial Metrics
Return on assets is -42.7%, showing how much profit it generates from its asset base. A current ratio of 0.29 means current liabilities exceed short-term assets, a liquidity point worth watching.
GGBXF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
GGBXF Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Wednesday
· Jan 29, 2020
-
Stocks That Hit 52-Week Lows On Monday
· Jan 27, 2020
-
Stocks That Hit 52-Week Lows On Tuesday
· Dec 17, 2019
GGBXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GGBXF.
Price Targets
Wall Street price target analysis for GGBXF.
GGBXF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GGBXF; grades run from A+ (80-100) to F (below 30).
Leadership: Ed Kistner
CEO
Ed Kistner serves as the CEO of Green Growth Brands Inc. His background includes experience in the retail and consumer goods sectors. Prior to joining Green Growth Brands, Kistner held leadership positions at various companies, focusing on strategic growth and operational efficiency. His expertise lies in brand management, market development, and financial performance. Kistner's appointment aimed to leverage his experience to drive growth and improve the company's financial performance in the competitive cannabis and CBD market.
Track Record: Since assuming the role of CEO, Ed Kistner has focused on streamlining operations and expanding the company's product offerings. Key initiatives include enhancing the e-commerce platform and forging strategic partnerships to broaden distribution channels. However, the company continues to face significant financial challenges, as reflected in its negative profit margins and market capitalization.
GGBXF OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market, indicating that Green Growth Brands Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity, higher price volatility, and a lack of transparency.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Potential for higher price volatility due to limited liquidity.
- Increased risk of fraud or mismanagement.
- Dependence on regulatory approvals and market acceptance.
- Limited access to capital markets.
- Verify the company's legal status and regulatory compliance.
- Review available financial statements and assess the company's financial health.
- Research the company's management team and their track record.
- Evaluate the company's business model and competitive positioning.
- Assess the liquidity and trading volume of the stock.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Established brand names in the cannabis and CBD market.
- Presence in key regional markets.
- Operational history dating back to 1968.
- Active engagement in the cannabis and CBD industry.
GGBXF Healthcare Stock FAQ
What do analysts say about GGBXF stock?
As of 2026-03-17, formal analyst coverage of Green Growth Brands Inc. (GGBXF) appears limited, likely due to its OTC listing and small market capitalization.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available for comprehensive analysis.
- OTC market investments carry higher risks.